arrow
返回

Evaluating Factor VIII Concentrates Using Clot Waveform Analysis

delete2024-06-30
delete2
delete
OA
AI
H
Hideo Wada *
K
Katsuya Shiraki
T
Takeshi Matsumoto
H
Hideto Shimpo
Y
Yumi Sakano
H
Hiroko Nishii
S
Shigehisa Tamaki
K
Kei Suzuki
I
Isao Tawara
Y
Yoshiki Yamashita
M
Motomu Shimaoka
DOI:10.3390/jcm13133857delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Background/Objectives: FVIII reagent activity varies across different assays, as well as activated partial thromboplastin time (APTT) reagents. The hemostatic ability of various FVIII reagents was examined via clot waveform analysis (CWA). Methods: APTT was measured using 12 APTT reagents, a small amount of tissue factor-induced FIX activation (sTF/FIXa) and a small amount of thrombin time (sTT) in order to examine 10 FVIII reagents and reference plasma (RP) using CWA. FVIII activity was measured using CWA-APTT, a chromogenic assay, or CWA-sTT. Results: Although the peak time (PT) and peak height (PH) of the CWA-APTT were markedly different in different FVIII reagents using several APTT reagents, the PTs of CWA-APTT were generally normal or shortened and the PHs of CWA-APTT were generally lower than those of RP. The FVIII activity varied, as evaluated using APTT, and was higher when using the CWA-sTT method than the APTT or chromogenic methods. CWA-sTT showed an elevated second peak of first DPH in all FVIII reagents, and both CWA-sTF/FIXa and CWA-sTT were enhanced using APTT reagents. Conclusions: Our evaluation of the hemostatic ability of FVIII reagents varied among APTT reagents. CWA-sTT can be used to further evaluate the hemostatic ability of an FVIII concentrate based on thrombin burst.
Keyword:
CWA
APTT reagent
sTF/FIX assay
FVIII
EHL-FVIII
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Journal of Clinical Medicine 封面图
Journal of Clinical Medicine
IF:
2.9
论文数:
5.1W
被引数:
9.8W

机构

M
Mie University
学者数:
5.8K
论文数: 4.3K
被引数: 2.8K
引用论文

引用论文

err分享
err收藏
err
IF0
err
err0
PREAI
err
err分享
err收藏
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
err2018-08-30
err516
errOAAI
errMahlangu, J.; Oldenburg, J.; Paz-Priel, I.; Negrier, C.; Niggli, M.; Mancuso, M. E.; Schmitt, C.; Jimenez-Yuste, V.; Kempton, C.; Dhalluin, C.; Callaghan, M. U.; Bujan, W.; Shima, M.; Adamkewicz, J. I.; Asikanius, E.; Levy, G. G.; Kruse-Jarres, R.
err分享
err收藏
A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab
err2022-10-18
err8
errOAAI
errWada, Hideo; Shiraki, Katsuya; Matsumoto, Takeshi; Suzuki, Kei; Yamashita, Yoshiki; Tawara, Isao; Shimpo, Hideto; Shimaoka, Motomu
err分享
err收藏
Hepatocyte swelling leads to rapid decrease of the G‐/total actin ratio and increases actin mRNA levels
err2001-12-17
err0
PREAI
errPanayotis A. Theodoropoulos; Christos Stournaras; Barbara Stoll; Emmanuel Markogiannakis; Florian Lang; Achilles Gravanis; Dieter Häussinger
err分享
err收藏
err分享
err收藏
Glaucoma progression detection using nonlocal Markov random field prior
err2014-12-29
err0
errOAAI
errAkram Belghith; Christopher Bowd; Felipe A. Medeiros; Madhusudhanan Balasubramanian; Robert N. Weinreb; Linda M. Zangwill
err分享
err收藏
学者 查看更多内容